Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
January 03 2019 - 8:00AM
Business Wire
- Webcast Available Through Ophthotech
Website -
Ophthotech Corporation (NASDAQ: OPHT) announced today that Glenn
P. Sblendorio, Chief Executive Officer and President, will present
an overview of the Company at the 37th Annual J.P. Morgan
Healthcare Conference in San Francisco, CA on Thursday, January 10,
2019 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
Investors and the general public are invited to listen to a live
webcast of the presentation at www.ophthotech.com. Please connect
to Ophthotech’s website several minutes prior to the start of the
presentation to ensure adequate time for any software download that
may be necessary. A replay will be available for 14 days following
the presentation.
About Ophthotech Corporation
Ophthotech is a biopharmaceutical company specializing in the
development of novel therapies to treat ophthalmic diseases, with a
focus on age-related and orphan retinal diseases. For more
information, please visit www.ophthotech.com.
Forward-looking Statements
Any statements in this press release about Ophthotech's future
expectations, plans and prospects constitute forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors. Any
forward-looking statements represent Ophthotech's views only as of
the date of this press release. Ophthotech anticipates that
subsequent events and developments will cause its views to change.
While Ophthotech may elect to update these forward-looking
statements at some point in the future, Ophthotech specifically
disclaims any obligation to do so.
OPHT-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190103005007/en/
InvestorsKathy GalanteOphthotech CorporationVice
President, Investor Relations and Corporate
Communications212-845-8231kathy.galante@ophthotech.com
MediaAlex Van ReesSmithSolve LLC on behalf of Ophthotech
Corporation973-442-1555 ext. 111alex.vanrees@smithsolve.com
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Sep 2024 to Oct 2024
OPHTHOTECH CORP. (NASDAQ:OPHT)
Historical Stock Chart
From Oct 2023 to Oct 2024